AMGN Gets FDA Nod, AGTC Awaits Data, THLD Initiates Tarloxotinib Trial

Amgen (AMGN) has been granted FDA approval for its cholesterol-lowering medication, Repatha (evolocumab) Injection. The drug is expected to be available in the U.S. next week.